Glycobiology Market Report and Forecast 2025-2034
Description
The global glycobiology market size was valued at USD 1.73 Billion in 2024, driven by the elevating recognition of the existence of glycans in biology across the globe. The market is anticipated to grow at a CAGR of 15.20% during the forecast period of 2025-2034 to achieve a value of USD 7.12 Billion by 2034.
Glycobiology: Introduction
Glycobiology is an area of study in which carbohydrates are studied that are also known as glycans. The carbohydrates and their role in different biological processes are studied in glycobiology. It is the study about the structure, functionality, and communications of glycan with lipids and other molecules present in living organisms. Carbohydrates play an important role in several biological processes such as cell-to-cell interaction, disease progression, and many others. In Glycobiology the role of carbohydrates in these processes is studies and how they can be used for treatments in various conditions as well.
Global Glycobiology Market Analysis
The primary trend aiding the global glycobiology market growth is the increasing focus of researchers on exploring the potential of glycans for treatment applications in healthcare industry. The therapeutic applications of glycans may include glycoconjugate vaccines, in order to treat diseases. The increasing focus on exploring therapeutic applications of glycans is a major trend in the market.
Additionally, the use of mass spectrometry and high-performance liquid chromatography has increased in order to characterize glycome of biological fluids, tissues, and cells. Glycobiology is slowly drifting towards exploring the functional efficiency of glycans from just studying the glycan structures.
Glycobiology plays a significant role in the development of personalized medicine, as glycans are involved in disease progression, drug response, and patient stratification. The increasing focus on developing personalized medicine is driving the demand for glycobiology research and diagnostic tools in the market. The increasing research and development activities in the field of glycobiology which is driven by the escalating comprehension of the role of glycans in various biological processes. This trend is leading to the discovery of new glycan-based biomarkers and therapeutic targets.
Global Glycobiology Market Segmentations
The EMR’s report titled “Glycobiology Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
The increasing interest in studies of glycans (carbohydrates) along with their benefits in biological systems is a major factor aiding the global glycobiology market development. The study of glycans has gathered comparatively more attention in past few years. The market for research of glycobiology and its applications is encountering stable growth and is expected to continue growing in the coming years.
Additionally, the increasing understanding of glycans and its importance in various biological processes and diseases is a major factor driving the glycobiology market expansion. There is a vital role that glycans play in cell-cell communication, immune response, protein folding and stability, and several other biological functions. As researchers reveal more information about the complex interactions between glycans and proteins, there is a growing demand for tools, technologies, and expertise in glycobiology.
In conclusion, the glycobiology market is witnessing growth due to the elevating recognition of the existence of glycans in biology and disease, the demand for equipment and technologies to study and alter glycans, and the potential uses of glycobiology in healthcare and pharmaceutical industries. The market is expected to continue expanding as research in glycobiology improves and more applications are found.
Glycobiology Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Glycobiology: Introduction
Glycobiology is an area of study in which carbohydrates are studied that are also known as glycans. The carbohydrates and their role in different biological processes are studied in glycobiology. It is the study about the structure, functionality, and communications of glycan with lipids and other molecules present in living organisms. Carbohydrates play an important role in several biological processes such as cell-to-cell interaction, disease progression, and many others. In Glycobiology the role of carbohydrates in these processes is studies and how they can be used for treatments in various conditions as well.
Global Glycobiology Market Analysis
The primary trend aiding the global glycobiology market growth is the increasing focus of researchers on exploring the potential of glycans for treatment applications in healthcare industry. The therapeutic applications of glycans may include glycoconjugate vaccines, in order to treat diseases. The increasing focus on exploring therapeutic applications of glycans is a major trend in the market.
Additionally, the use of mass spectrometry and high-performance liquid chromatography has increased in order to characterize glycome of biological fluids, tissues, and cells. Glycobiology is slowly drifting towards exploring the functional efficiency of glycans from just studying the glycan structures.
Glycobiology plays a significant role in the development of personalized medicine, as glycans are involved in disease progression, drug response, and patient stratification. The increasing focus on developing personalized medicine is driving the demand for glycobiology research and diagnostic tools in the market. The increasing research and development activities in the field of glycobiology which is driven by the escalating comprehension of the role of glycans in various biological processes. This trend is leading to the discovery of new glycan-based biomarkers and therapeutic targets.
Global Glycobiology Market Segmentations
The EMR’s report titled “Glycobiology Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Enzymes
- Instruments
- Reagents
- Kits
- Drug Discovery and Development
- Disease Diagnostics
- Virology
- Cell Biology
- Oncology
- Others
- Research Institutes
- Diagnostic Centers
- Hospitals
- Clinical Laboratories
- Pharmaceutical and Biotechnology Companies
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The increasing interest in studies of glycans (carbohydrates) along with their benefits in biological systems is a major factor aiding the global glycobiology market development. The study of glycans has gathered comparatively more attention in past few years. The market for research of glycobiology and its applications is encountering stable growth and is expected to continue growing in the coming years.
Additionally, the increasing understanding of glycans and its importance in various biological processes and diseases is a major factor driving the glycobiology market expansion. There is a vital role that glycans play in cell-cell communication, immune response, protein folding and stability, and several other biological functions. As researchers reveal more information about the complex interactions between glycans and proteins, there is a growing demand for tools, technologies, and expertise in glycobiology.
In conclusion, the glycobiology market is witnessing growth due to the elevating recognition of the existence of glycans in biology and disease, the demand for equipment and technologies to study and alter glycans, and the potential uses of glycobiology in healthcare and pharmaceutical industries. The market is expected to continue expanding as research in glycobiology improves and more applications are found.
Glycobiology Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Shimadzu Corporation
- Takara Bio Inc.
- Promega Corporation
- Danaher Corporation
- AMS Bio
- Sumitomo Bakelite Co. Ltd.
- Dextra Laboratories Ltd.
- RayBiotech, Inc.
- Waters Corporation
- Glycotope GmbH
- New England Biolabs, Inc.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Glycobiology Market Overview
- 3.1 Global Glycobiology Market Historical Value (2018-2024)
- 3.2 Global Glycobiology Market Forecast Value (2025-2034)
- 4 Global Glycobiology Market Landscape
- 4.1 Global Glycobiology Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Glycobiology Product Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Application
- 5 Global Glycobiology Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Glycobiology Market Segmentation
- 6.1 Global Glycobiology Market by Product
- 6.1.1 Market Overview
- 6.1.2 Enzymes
- 6.1.3 Instruments
- 6.1.4 Reagents
- 6.1.5 Kits
- 6.2 Global Glycobiology Market by Application
- 6.2.1 Market Overview
- 6.2.2 Drug Discovery and Development
- 6.2.3 Disease Diagnostics
- 6.2.4 Virology
- 6.2.5 Cell Biology
- 6.2.6 Oncology
- 6.2.7 Others
- 6.3 Global Glycobiology Market by End User
- 6.3.1 Market Overview
- 6.3.2 Research Institutes
- 6.3.3 Diagnostic Centers
- 6.3.4 Hospitals
- 6.3.5 Clinical Laboratories
- 6.3.6 Pharmaceutical and Biotechnology Companies
- 6.3.7 Others
- 6.4 Global Glycobiology Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Glycobiology Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Glycobiology Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Glycobiology Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Glycobiology Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Glycobiology Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Merck KGaA
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Thermo Fisher Scientific Inc.
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Shimadzu Corporation
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Takara Bio Inc.
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Promega Corporation
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Danaher Corporation
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 AMS Bio
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Sumitomo Bakelite Co. Ltd.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Dextra Laboratories Ltd.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 RayBiotech, Inc.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Waters Corporation
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Glycotope GmbH
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 New England Biolabs, Inc.
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 18 Global Glycobiology Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
